In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

CMS proposes new indications for implanted cardiac pacemakers, declines coverage reconsideration request from Cyberonics. Trustees project Medicare solvency until 2026. More reimbursement briefs.

You may also be interested in...



Cardiac Pacemaker National Medicare Coverage Policy Updated

CMS issued a final decision memo Aug. 13 to cover implantation of permanent single- and dual-chamber cardiac pacemakers for documented nonreversible symptomatic bradycardia due to sinus node dysfunction and second- and/or third-degree atrioventricular block.

Reimbursement In Brief

CMS issues coverage proposal for bariatric surgery and receives comments on its pacemaker coverage proposal. More reimbursement briefs.

Stakeholders Support Revision Of National Coverage Determination For Cardiac Pacemakers

Stakeholders support the Heart Rhythm Society and the American College of Cardiology’s request that CMS update the 27-year-old clinical indications for group II, dual-chamber pacemakers.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

WI964947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel